Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
Operating Income
Wuhan Easy Diagnosis Biomedicine Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Operating Income
¥5.1B
|
CAGR 3-Years
435%
|
CAGR 5-Years
134%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Operating Income
¥574.3m
|
CAGR 3-Years
69%
|
CAGR 5-Years
87%
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Operating Income
¥2.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
25%
|
CAGR 10-Years
23%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Operating Income
¥10.5B
|
CAGR 3-Years
28%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Operating Income
¥2.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Operating Income
¥1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Operating Income?
Operating Income
5.1B
CNY
Based on the financial report for Dec 31, 2022, Wuhan Easy Diagnosis Biomedicine Co Ltd's Operating Income amounts to 5.1B CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
134%
Over the last year, the Operating Income growth was 204%. The average annual Operating Income growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been 435% over the past three years , 134% over the past five years .